A clinical study to compare pharmacokinectic characteristics of Eperisone Hydrochloride and Aceclofenac with HCP1104 treatment to those of co-administration of Eperisone Hydrochloride 50mg tablet and Aceclofenac 100mg tablet in healthy adult male volunteers
Not Applicable
Completed
- Conditions
- Not Applicable
- Registration Number
- KCT0000907
- Lead Sponsor
- Hanmi Pharm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
1) Healthy male volunteers, age between 20 and 45
2) BMI of >20kg/m2 and <28kg/m2 subject
3) Informed of the investigational nature of this study and voluntarily agree to participate in this study
Exclusion Criteria
1) Use of any prescription medication within 14 days prior to Day 1
2) Use of any medication within 7 days prior to Day 1
3) Participation in another clinical study within 60 days prior to start of study drug administration
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AUClast;Cmax
- Secondary Outcome Measures
Name Time Method AUC0-12;AUCinf;MRTlast